FDA Inspection 1338948 — LEO Pharma Ireland
The FDA completed an inspection of LEO Pharma Ireland on Jan 30, 2026 in Dublin 12. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin 12 (Ireland)
Additional Details
Mutual Recognition Agreement (MRA)